We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$53.7B
1-Year Est. Return
29.47%
This Fund
S&P 500
This Quarter
Est. Return
-3.67%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
–
AUM
$40.3B
AUM Growth
-$1.82B
(-4.3%)
Cap. Flow
+$332M
Cap. Flow
% of AUM
0.83%
Top 10 Holdings %
Top 10 Hldgs %
25.24%
Holding
2,393
New
237
Increased
785
Reduced
642
Closed
83
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Mastercard
MA
|
+$231M |
| 2 |
Gilead Sciences
GILD
|
+$113M |
| 3 |
PG&E
PCG
|
+$102M |
| 4 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$80.2M |
| 5 |
Allstate
ALL
|
+$64.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$472M |
| 2 |
AbbVie
ABBV
|
+$121M |
| 3 |
iShares MSCI USA Value Factor ETF
VLUE
|
+$69.5M |
| 4 |
Salesforce
CRM
|
+$64.3M |
| 5 |
Home Depot
HD
|
+$62.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.24% |
| 2 | Healthcare | 19.03% |
| 3 | Financials | 13.02% |
| 4 | Consumer Discretionary | 9.39% |
| 5 | Industrials | 7.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
776
Gentex
GNTX
$5.12B
| $2.02M | 0.01% |
84,961
-860
| -1% | -$23.6K |
|
|
TWTR
777
DELISTED
Twitter, Inc.
TWTR
| $2.02M | 0.01% |
46,168
+18,250
| +65% | +$743K |
|
778
CubeSmart
CUBE
$9.62B
| $2.01M | 0.01% |
50,280
+18,285
| +57% | +$824K |
|
779
Wayfair
W
$12.5B
| $2.01M | 0.01% |
61,855
-1,098
| -2% | -$58K |
|
780
Healthcare Realty
HR
$7.58B
| $2.01M | 0.01% |
+96,428
| New | +$2.45M |
|
781
MDU Resources
MDU
$4.31B
| $2.01M | 0.01% |
193,368
-12,649
| -6% | -$140K |
|
782
Highwoods Properties
HIW
$3.71B
| $2.01M | 0.01% |
74,481
-17,780
| -19% | -$574K |
|
783
WillScot Mobile Mini Holdings
WSC
$4.66B
| $2M | 0.01% |
49,500
+34,030
| +220% | +$1.33M |
|
784
AXIS Capital
AXS
$8.79B
| $1.99M | ﹤0.01% |
40,480
+26,385
| +187% | +$1.4M |
|
785
Gossamer Bio
GOSS
$100M
| $1.98M | ﹤0.01% |
165,616
+4,510
| +3% | +$56K |
|
|
JNPR
786
DELISTED
Juniper Networks
JNPR
| $1.98M | ﹤0.01% |
75,767
+27,820
| +58% | +$785K |
|
787
ManpowerGroup
MAN
$2.58B
| $1.97M | ﹤0.01% |
30,398
-22,740
| -43% | -$1.71M |
|
|
AZPN
788
DELISTED
Aspen Technology Inc
AZPN
| $1.97M | ﹤0.01% |
8,259
| – | – |
|
789
Viridian Therapeutics
VRDN
$2.15B
| $1.96M | ﹤0.01% |
95,775
+74,370
| +347% | +$1.34M |
|
|
RETA
790
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $1.96M | ﹤0.01% |
78,115
+15,379
| +25% | +$426K |
|
791
WEX
WEX
$6.23B
| $1.96M | ﹤0.01% |
15,433
-770
| -5% | -$121K |
|
792
Canadian Imperial Bank of Commerce
CM
$109B
| $1.95M | ﹤0.01% |
40,700
| – | – |
|
793
Ashland
ASH
$3.11B
| $1.93M | ﹤0.01% |
20,320
-940
| -4% | -$95.6K |
|
794
Zimmer Biomet
ZBH
$18.5B
| $1.93M | ﹤0.01% |
18,441
-144,115
| -89% | -$15.8M |
|
795
Penumbra
PEN
$12.6B
| $1.93M | ﹤0.01% |
10,160
-1,040
| -9% | -$167K |
|
796
Primerica
PRI
$10B
| $1.93M | ﹤0.01% |
15,596
-990
| -6% | -$125K |
|
797
Regenxbio
RGNX
$615M
| $1.92M | ﹤0.01% |
72,610
+4,499
| +7% | +$133K |
|
798
Alcon
ALC
$33.7B
| $1.9M | ﹤0.01% |
29,874
+1,300
| +5% | +$90.2K |
|
799
Kinsale Capital Group
KNSL
$8.43B
| $1.89M | ﹤0.01% |
7,400
-600
| -8% | -$150K |
|
800
Organon & Co
OGN
$3.55B
| $1.89M | ﹤0.01% |
80,695
+2,840
| +4% | +$85.7K |
|
Similar funds
SCP
Ensign Peak Advisors's Q3 2022 Portfolio in Review
As of Q3 2022, Ensign Peak Advisors held 2,393 positions worth $40.3B, down 4.3% from $42.1B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Ensign Peak Advisors's Q3 2022 filing shows 237 new, 785 increased, 642 reduced and 83 closed positions. Its largest new stake was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M. The largest sale was Visa, an estimated $472M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q3 2022 buy was iShares 1-3 Year Treasury Bond ETF: 975,000 shares worth $79.2M.
- Ensign Peak Advisors added most to Mastercard in Q3 2022, an estimated $231M increase.
- Ensign Peak Advisors's biggest Q3 2022 reduction was AbbVie, cutting an estimated $121M.
- Ensign Peak Advisors fully exited Visa in Q3 2022, selling an estimated $472M.
- Ensign Peak Advisors's ten largest holdings make up 25% of its $40.3B portfolio in Q3 2022.
- Ensign Peak Advisors opened 237 new positions and closed 83 in Q3 2022.
- Ensign Peak Advisors's portfolio value fell 4.3% quarter-over-quarter to $40.3B.
Based on Ensign Peak Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.